-
-
There is no doubt now that the cervical length (CL) measurement, obtained with transvaginal ultrasound between 20 and 24 weeks, can give the clinician a very reasonable idea about which patients have the greatest and smallest chances of delivering preterm.
-
Worldwide, coffee is a popular beverage used daily with increasing frequency. Caffeine, a dominant ingredient, has been implicated in many conditions including hormonally active cancer (due to its impact on sex hormone binding globulin [SHBG] homeostasis).
-
The Annual Meeting of the Society of Gynecologic Oncologists (SGO) represents the one completely focused platform to exchange preclinical and clinical information in the subspeciality of gynecologic oncology. This year more that 1300 health care providers, researchers and industry representatives participated in a conference offering much more than distribution of the latest scientific and clinical advances.
-
As clinicians begin to integrate use of the first cervical cancer vaccine (Gardasil, Merck & Co.; Whitehouse Station, NJ), the Food and Drug Administration (FDA) is set to review the application for a second vaccine.
-
Update your practice when it comes to treatment of gonorrhea: The Centers for Disease Control and Prevention (CDC) no longer recommends the fluoroquinolone antibiotics ciprofloxacin, ofloxacin, and levofloxacin as a treatment for gonorrhea in the United States.
-
Consider the following patients: a 15-year-old young mother, a 30-year-old married woman with no previous pregnancies, a 30-year-old single woman with no children, and a 30-year-old HIV-positive woman with three children. When discussing contraceptive options, do you include intrauterine contraception in talking with these women?
-
In 1992, reproductive health advocates estimated that emergency contraceptive pills (ECPs) could prevent half of all unintended pregnancies and abortions in the United States each year.
-
Global policies are being updated with the recent issuance of recommendations from an expert consultation on male circumcision for HIV prevention.1 But what impact do the recommendations have on your practice?
-
Has your treatment of menopausal women changed since the initial findings released from the Women's Health Initiative (WHI) randomized, controlled trials of hormone therapy (HT)? Findings from a just-published secondary analysis of data from the WHI indicate that women who initiated HT closer to menopause tended to have reduced risk of coronary heart disease (CHD), while women further from menopause tended to have a slightly higher risk for the disease.